Differential regulation of corticosteroid receptors by monoamine neurotransmitters and antidepressant drugs in primary hippocampal culture

Neuroscience

Volumn 118, Issue 4, 2003, Pages 975-984

  Lai, M ^a   McCormick, J A ^a   Chapman, K E ^a   Kelly, P A T ^a   Seckl, J R ^a   Yau, J L W ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Brain; Glucocorticoid receptor; Mineralocorticoid receptor; Noradrenaline; Serotonin

Indexed keywords

3 [2 [2 (4 METHYL 1 PIPERIDINYL)ETHYL] 1 PYRROLIDINESULFONYL]PHENOL; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR; CORTICOSTEROID RECEPTOR; FLUOXETINE; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; MINERALOCORTICOID; MINERALOCORTICOID RECEPTOR; MONOAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROTRANSMITTER; NORADRENALIN; PROPRANOLOL; PROTEIN; SEROTONIN; SEROTONIN 7 RECEPTOR; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NERVE CELL CULTURE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; RECEPTOR UPREGULATION;

EID: 0038066569     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00038-1     Document Type: Article

References (60)

1. Barden N. Modulation of glucocorticoid receptor gene expression by antidepressant drugs. Pharmacopsychiatry. 29:1996;12-22.
2. Booze R.M., Crisostomo E.A., Davis J.N. β-adrenergic receptors in the hippocampal and retro-hippocampal regions of rats and guinea pigs autoradiographic and immunohistochemical studies . Synapse. 13:1993;206-214.
3. Bradbury M.J., Akana S.F., Dallman M.F. Roles of the type I and II corticosteroid receptors in the regulation of basal activity in the hypothalamic-pituitary adrenal axis during the diurnal trough and peak evidence for non additive effect of combined receptor occupancy . Endocrinology. 134:1994;1286-1296.
4. Budziszewska B., Jaworska-Feil L., Kajta M., Lason W. Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription a possible mechanism . Br J Pharmacol. 130:2000;1385-1393.
5. Chalmers D.T., Watson S.J. Comparative anatomical distribution of 5HT1A receptor mRNA and 5HT1A binding in rat brain - a combined in situ hybridisation/in vitro receptor autoradiographic study. Brain Res. 561:1991;51-60.
6. 1A receptor mRNA expression. J Neurosci. 13:1993;914-923.
7. Chen J.J., Rasenick M.M. Chronic treatment of C6 glioma cells with antidepressant drugs increases functional coupling between a G protein (Gs) and adenylyl cyclase. J Neurochem. 64:1995;724-732.
8. de Kloet E.R., Vreugdentil E., Oitzl M.S., Joels M. Brain corticosteroid receptor balance in health and disease. Endocr Rev. 19:1998;269-301.
9. Erdeljan P., MacDonald J.F., Matthew S.G. Glucocorticoids and serotonin alter glucocorticoid receptor but not mineralocorticoid receptor mRNA levels in fetal mouse hippocampal neurons in vitro. Brain Res. 896:2001;130-136.
10. Evans R.M. The steroid and thyroid hormone receptor superfamily. Science. 240:1988;889-895.
11. Feldman S., Weidenfeld J. Glucocorticoid receptor antagonists in the hippocampus modify the negative feedback following neural stimuli. Brain Res. 821:1999;33-37.
12. Forster E. An improved general method to generate internal standards for competitive PCR. Biotechniques. 16:1994;18-20.
13. 7 receptor in the rat brain. Br J Pharmacol. 117:1996;657-666.
14. 7 antagonist. Br J Pharmacol. 130:2000;539-548.
15. Hery M., Semont A., Fache M.P., Faudon M., Hery F. The effects of serotonin on glucocorticoid receptor binding in rat raphe nuclei and hippocampal cell culture. J Neurochem. 74:2000;406-413.
16. Heuser L., Yassouridid A., Holsboer F. The combined dexamethasone/CRH test a refined laboratory test for psychiatric disorders . J Psychiatr Res. 28:1994;341-356.
17. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr Rev. 17:1996;187-205.
18. Holsboer F. The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology. 23:2000;477-501.
19. Horner H.C., Packan D.R., Sapolsky R.M. Glucocorticoids inhibit glucose transport in cultured hippocampal neurones and glia. Neuroendocrinology. 52:1990;57-61.
20. Inazu M., Takeda H., Ikoshi H., Sugisawa M., Uchida Y., Matsumiya T. Pharmacological characterisation and visualisation of the glial serotonin transporter. Neurochem Int. 39:2001;39-49.
21. Jacobson L., Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr Rev. 12:1991;118-134.
22. Joels M., de Kloet E.R. Corticosteroid actions on amino acid mediated transmission in rat CA1 hippocampal cells. J Neurosci. 13:1993;4082-4090.
23. Kabbaj M., Piazza P.V., Simon H., Le Moal M., Maccari S. Opposite effects of hippocampal corticosteroid receptors induced by stimulation of α and β1 noradrenergic receptors. Neuroscience. 66:1995;539-545.
24. Karst H., Wadman W.J., Joels M. Corticosteroid receptor dependent modulation of calcium currents in rat hippocampus CA1 neurons. Brain Res. 649:1994;234-242.
25. Linkowski P., Mendlewicz J., Le Clerq R., Brasseur M., Hubain P., Golstein J., Copinschi G., Cauter E.V. The 24 hr profile of adrenocorticotropin and cortisol in major depressive illness. J Clin Endocrinol Metab. 61:1985;429-438.
26. 1A, glucocorticoid and mineralocorticoid receptor in rat and human hippocampus implications for the neurobiology of depression . Biol Psychiatry. 43:1998;547-573.
27. 7 anatgonist. J Med Chem. 43:2000;342-345.
28. Maccari S., Mormede P., Piazza P.V., Simon H., Angelucci L., Le Moal M. Hippocampal type I and type II corticosteroid receptors are modulated by central noradrenergic systems. Psychoneuroendocrinology. 17:1992;103-112.
29. McCullers D.L., Herman J.P. Mineralocorticoid receptors regulate bcl-2 and p53 mRNA expression in rat hippocampus. Neuroreport. 9:1998;3085-3089.
30. McQuade R., Young A.H. Future therapeutic targets in mood disorders the glucocorticoid receptor . Br J Pharmacol. 177:2000;390-395.
31. Meltzer H. Serotonergic dysfunction in depression. Br J Psychiatry. 155:1989;25-31.
32. Mitchell J.B., Row W., Boksa P., Meaney M.J. Serotonin regulates type II corticosteroid receptor binding in hippocampal cell cultures. J Neurosci. 10:1990;1745-1752.
33. Mitchell J.B., Betito K., Rowe W., Boksa P., Meaney M.J. Serotonergic regulation of type II corticosteroid receptor binding in hippocampal cell cultures evidence or the importance of serotonin-induced changes in cAMP levels . Neuroscience. 48:1992;631-639.
34. Nicholas A.P., Pieribone V.A., Hokfelt T. Cellular localisation of messenger RNA for beta-1 and beta-2 adrenergic receptors in rat brain an in situ hybridisation study . Neuroscience. 56:1993;1023-1039.
35. Okugawa G., Omori K., Suzukawa J., Fujiseka Y., Kinoshita T., Inagaki C. Long term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultures rat hippocampal neurons. J Neuroendocrinol. 11:1999;887-895.
36. Pariante C.M., Makoff A., Lovestone S., Feroli S., Heyden A., Miller A.H., Kerwin R.W. Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters. Br J Pharmacol. 134:2001;1335-1343.
37. Pariante C.M., Miller A. Glucocorticoid receptors in major depression relevance to pathophysiology and treatment . Biol Psychiatry. 49:2001;391-404.
38. Pariante C.M., Pearce B.D., Pisell T.L., Owens M.J., Miller A.H. Steroid independent translocation of glucocorticoid receptor by the antidepressant desipramine. Mol Pharmacol. 52:1997;571-581.
39. Pepin M.C., Beaulieu S., Barden N. Antidepressants regulate glucocorticoid receptor messenger RNA concentrations in primary neuronal cultures. Mol Brain Res. 6:1989;77-83.
40. Pepin M.C., Pothier F., Barden N. Antidepressant drug action in a transgenic mouse model of the endocrine changes seen in depression. Mol Pharmacol. 42:1993;991-995.
41. Pompeiano M., Palacios J.M., Mengod G. Distribution and cellular localisation of mRNA coding for 5HT1A receptor in the rat brain: correlation with receptor binding. J Neurosci. 12:1992;440-453.
42. Raber J. Detrimental effects of chronic hypothalamic-pituitary adrenal axis activation from obesity to memory deficits. Mol Neurobiol. 18:1998;1-22.
43. Reul J.M.H.M., de Kloet E.R. Two receptor systems for corticosterone in rat brain microdistribution and differential occupation . Endocrinology. 117:1985;2505-2511.
44. Reul J.M.H.M., Stec I., Soder M., Holsboer F. Chronic amitriptyline attenuates the activity of the hypothalamic-pituitary-adrenocortical system. Endocrinology. 133:1993;512-520.
45. Rosenfeld P., Van Eekelen J.A., Levine S., de Kloet E.R. Ontogeny of corticosteroid receptors in the brain. Cell Mol Neurobiol. 13:1993;295-319.
46. Rossby S.P., Nalepas I., Huang M., Perrin C., Burt A.M., Schmidt D.E., Gillespie D.D., Sulser F. Norepinephrine-independent regulation of GR II mRNA in vivo by a tricyclic antidepressant. Brain Res. 687:1995;79-82.
47. Schreiber W., Lauer C.J., Krumrey K., Holsboer F., Krieg J.C. Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder. Neuropsychopharmacology. 15:1996;7-15.
48. Seckl J.R., Dickson K.L., Fink G. Central 5,7,dihydroxytryptamine lesions decrease hippocampal glucocorticoid and mineralocorticoid receptor messenger ribonucleic acid expression. J Neuroendocrinol. 2:1990;911-916.
49. Seckl J.R., Fink G. Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in the rat hippocampus in vivo. Neuroendocrinology. 55:1992;621-626.
50. Semont A., Fache M.-P., Hery F., Faudon M., Youssouf F., Hery M. Regulation of central corticosteroid receptors following short-term activation of serotonin transmission by 5-hydroxy-L-tryptophan or fluoxetine. J Neuroendocrinol. 12:2000;736-744.
51. Spencer R.L., Kim P.J., Kalman B.A., Cole M.A. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor dependent regulation of the HPA axis activity. Endocrinology. 138:1998;2718-2726.
52. Steel M., Buckley N.J. Differential regulation of muscarinic receptor mRNA levels in neuroblastoma cells by chronic agonist exposure a comparative polymerase chain reaction study . Mol Pharmacol. 43:1993;694-701.
53. 3H] 5-carboxytryptamine. Neuropharmacology. 37:1998;1611-1619.
54. Thome J., Sakai N., Shin K., Steffen C., Zhang Y.J., Impey S., Storm D., Duman R.S. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci. 20:2000;4030-4036.
55. Van Eekelen J.A., Jiang W., de Kloet E.R., Bohn M.C. Distribution of the mineralocorticoid and the glucocorticoid receptor mRNAs in the rat hippocampus. J Neurosci Res. 21:1988;88-94.
56. von Bardeleben U., Holsboer F. Cortisol response to a combined dexamethasone-human corticotropin-releasing hormone challenge in patients with depression. J Neuroendocrinol. 1:1989;485-488.
57. Yamamoto M., Steinbusch H.W.M., Jessell T.M. Differential properties of identified serotonin neurons in dissociated cultures of embryonic rat brain stem. J Cell Biol. 91:1981;142-152.
58. Yau J.L.W., Seckl J.R. Central 6-hydroxydopamine lesions decrease mineralocorticoid but not glucocorticoid receptor gene expression in the rat hippocampus. Neurosci Lett. 142:1992;159-162.
59. 1C receptor gene expression in the rat hippocampus. Neuroscience. 61:1994;31-40.
60. 7 receptor mRNA expression in the rat hippocampus. Neurosci Lett. 309:2001;141-144.